Business
RENX to present at 40th JP Morgan Healthcare Conf.
RENX to present at 40th JP Morgan Healthcare Conf..
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4318X\n Renalytix PLC\n 05 January 2022\n \n \n \n \n \n \n \n Renalytix plc\n \n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference\n \n \n \n \n \n \n LONDON and SALT LAKE CITY, January 5, 2022\n \n - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company will be presenting at the upcoming 40th Annual J.P. Morgan Virtual Healthcare Conference.\n \n \n \n \n \n Renalytix's management is scheduled to present on Wednesday, January 12 2022, at 2:15 p.m. EST. Interested parties may access a live and archived webcast of the presentation on the \"Investors\" section of the company website at investors.renalytix.com.\n \n \n \n \n \n About Renalytix\n \n \n Renalytix (NASDAQ: RNLX) (LSE: RENX) is the global founder and leader in the new field of bioprognosis™ for kidney health. The company has engineered a new solution that successfully enables early-stage CKD progression risk assessment. The Company's lead product, KidneyIntelX, has been granted Breakthrough Designation by the U.S. Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com). For more information, visit \n www.renalytix.com\n .\n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n Renalytix plc \n \n \n \n \n \n \n www.renalytix.com\n \n \n \n \n \n \n \n \n James McCullough, CEO \n \n \n \n \n Via Walbrook PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser, \n \n \n Joint Broker\n \n \n )\n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n Alex Price / \n Nicholas Moore\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n Gary Clarence / Daniel Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n Tel: 020 7933 8780 \n \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus / Lianne Applegarth\n \n...